跳至主要内容
临床试验/NCT01866085
NCT01866085Unknown不适用

Randomised Clinical Trial to Evaluate Efficacy of AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence

Jewish General Hospital1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2012年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
128
试验地点
1
主要终点
Patient satisfaction using the Patient Global Impression of Improvement (PGI-I) score and assess change in 24-hour pad weight .

研究概览

简要总结

The study is designed to assess efficacy and subject satisfaction of two sling devices: Advance and Argus, in male patients with stress urinary incontinence after prostatectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •The subject is male
  • •The subject is at least 18 years of age
  • •The subject has an estimated life expectancy of more than 5 years
  • •The subject has confirmed stress urinary incontinence (SUI) through medical history, urodynamics, and/or physical exam for at least 6 months
  • •The subject has intrinsic sphincter deficiency due to one of the following:
  • •post-TURP, simple open prostatectomy, radical prostatectomy completed at least 6 months prior to implantation date
  • •Positive Cough Stress Test (CST):
  • •Positive 24-hours Pad Test (PT):
  • •A positive PT is confirmed with leakage of >8.O g/24h and < 400 g
  • •The subject has completed urodynamics, uroflow, post-void residual, and cystoscopy as per the protocol within 6 months prior to implant
  • •The subject is able and willing to complete all follow-up visits and procedures indicated in this protocol
  • •The subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the local ethics commit-tee of the respective site

排除标准

  • •Subjects who meet any of the following criteria are excluded from entry into the study
  • •The subject is unable or unwilling to sign the Informed Consent Form (ICF) and/or comply with all follow-up requirements according to the study protocol
  • •The subject has an active urogenital infection or active skin infection in region of surgery
  • •The subject has serious bleeding disorders
  • •The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, CVA, detrusor-external sphincter dyssynergia, Parkinson's disease, or similar conditions
  • •The subject had a previous implant to treat stress urinary incontinence
  • •The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months
  • •The subject is likely to undergo radiation therapy within the next 6 months
  • •The subject has active urethral or bladder neck stricture disease, requiring continued treatment
  • •The subject has urge predominant incontinence
  • •The subject has an atonic bladder or a postvoid residual (PVR) ≥150mL
  • •The subject has a condition or disorder likely to require future transurethral procedure
  • •The subject is enrolled in a concurrent clinical trial of any treatment (drug or device) that could affect continence function without the sponsors'approval
  • •Subjects who in the opinion of the investigator are unable and/or unlikely to to comprehend the nature, scope and possible consequences of the study and to follow the study procedures and instructions and complete all study related measurements.

研究组 & 干预措施

AdVance

Active Comparator

sling procedure

干预措施: AdVance® sling procedure (Procedure)

ARGUS

Active Comparator

sling procedure

干预措施: ARGUS Sling procedure (Procedure)

结局指标

主要结局

Patient satisfaction using the Patient Global Impression of Improvement (PGI-I) score and assess change in 24-hour pad weight .

时间窗: 12 months

次要结局

  • Assess change in subject satisfaction using questionnaires: ICIQ, UCLA-RAND Incontinence Index.(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacques Corcos

MD. Professor of Urology, McGill University

Jewish General Hospital

研究点 (1)

Loading locations...

相似试验